Judge Dismisses Most Of Painkiller Lawsuit Against NFL Teams
Photo credit: Jack Dempsey/ [object Object] A U.S. District Court judge has dismissed most of the lawsuit that was brought by former players against NFL teams, alleging that those teams broke federal drug laws and doled out reckless quantities of pain killers, resulting in various long-term health problems.
Judge William Alsup criticized the the lawsuit and contended that it contained little evidence to support the claim that the NFL players’ health problems resulted from the treatment they received from team doctors. He wrote:
[Even assuming that] the lead plaintiffs and their various ailments are a representative sample of the overall population of NFL retirees, that alone would still be insufficient to plead causation. Statistically, in any population as large as NFL retirees, some incidence of tumors and other organ-related ailments is to be expected, so the mere presence of such ailments does not speak to etiology.
He also called the players’ amended complaint “disorganized, frequently boilerplate, and sometimes contradictory,” which made it “difficult to understand specific claims for relief asserted against individual clubs.”
The judge dismissed the whole lawsuit except for 12 claims of intentional misrepresentation. The players and their lawyers can appeal the ruling.
WNBA Overreacted to Angel Reese and Paige Bueckers’ $400 Bet
Ohio State Reloads for 2026 With Brutal Schedule Ahead
Vita Vea Requests Trade, and the Rams Make Too Much Sense
WNBA Picks Tuesday: Best Bets for Lynx, Fever and Aces
- MLB Best Bets for Sunday's Rockies vs. Brewers, Yankees vs. Phillies
- UFC Abu Dhabi Best Bets: Top Picks for Ankalaev vs. Guskov Fight Night
- WNBA All-Star Weekend Best Bets: Caitlin Clark, Marina Mabrey and More
- MLB Player Props Today: Best Bets for Wednesday, July 22
- WNBA Best Bets: Wednesday Picks Featuring Lynx, Aces and Wings
- Twins vs. Guardians Prediction: Best Bets for Tuesday's AL Central Showdown
- MLB Best Bets: Jacob Misiorowski, Dylan Cease Lead Monday's Top Picks

